Cargando…
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells
Background: Malignant Pleural Mesothelioma (MPM) is an aggressive tumor that has a significant incidence related to asbestos exposure with no effective therapy and poor prognosis. The role of mesenchymal stromal cells (MSCs) in cancer is controversial due to their opposite effects on tumor growth an...
Autores principales: | Coccè, Valentina, La Monica, Silvia, Bonelli, Mara, Alessandri, Giulio, Alfieri, Roberta, Lagrasta, Costanza Annamaria, Madeddu, Denise, Frati, Caterina, Flammini, Lisa, Lisini, Daniela, Marcianti, Angela, Parati, Eugenio, Paino, Francesca, Giannì, Aldo, Farronato, Giampietro, Falco, Angela, Spaggiari, Lorenzo, Petrella, Francesco, Pessina, Augusto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227879/ https://www.ncbi.nlm.nih.gov/pubmed/34201002 http://dx.doi.org/10.3390/cells10061427 |
Ejemplares similares
-
Automated Large-Scale Production of Paclitaxel Loaded Mesenchymal Stromal Cells for Cell Therapy Applications
por: Lisini, Daniela, et al.
Publicado: (2020) -
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
por: Cordani, Nicoletta, et al.
Publicado: (2023) -
Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021) -
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
por: La Monica, Silvia, et al.
Publicado: (2019) -
Development of Biomimetic Alginate/Gelatin/Elastin Sponges with Recognition Properties toward Bioactive Peptides for Cardiac Tissue Engineering
por: Rosellini, Elisabetta, et al.
Publicado: (2020)